Gaucher disease type I: Assessment of basal metabolic rate in patients from southern Brazil

Blood Cells, Molecules, and Diseases

Volumn 46, Issue 1, 2011, Pages 42-46

  Doneda, Divair ^a   Lopes, André L ^a   Oliveira, Alvaro R ^a   Netto, Cristina B ^b   Moulin, Cileide C ^a   Schwartz, Ida V D ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Energy Metabolism; Gaucher Disease; Indirect Calorimetry; Nutritional Status

Indexed keywords

IMIGLUCERASE;

ADOLESCENT; ADULT; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REPLACEMENT; FEMALE; FOLLOW UP; GAUCHER DISEASE; GAUCHER DISEASE TYPE 1; HUMAN; MALE; NUTRITIONAL STATUS; OBESITY; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; BASAL METABOLISM; BODY WEIGHT; BRAZIL; CASE-CONTROL STUDIES; FEMALE; GAUCHER DISEASE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650843193     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.10.008     Document Type: Article

References (28)

1. Hruska K.S., Lamarca M.E., Sidransky E. Gaucher Disease: Molecular Biology and Genotype-Phenotype Correlations. Gaucher Disease 2007, 13-48. CRC Taylor & Francis, Boca Raton. A.H. Futerman, A. Zimran (Eds.).
2. Grabowski G.A. Gaucher disease: lessons from a decade of therapy. J. Pediatr. 2004, 144(5 Suppl):S15-S19.
3. Barton D.J., Ludman M.D., Benkov K., Grabowski G.A., LeLeiko N.S. Resting energy expenditure in Gaucher's disease type 1: effect of Gaucher's cell burden on energy requirements. Metabolism 1989, 38:1238-1243.
4. Corssmit E.P., Hollak C.E., Endert E., van Oers M.H., Sauerwein H.P., Romijn J.A. Increased basal glucose production in type 1 Gaucher's disease. J. Clin. Endocrinol. Metabol. 1995, 80:2653-2657.
5. Hollak C.E., CorssmiT E.P., Aerts J.M., Endert E., Sauerwein H.P., Romijn J.A., van Oers M.H. Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease. Am. J. Med. 1997, 103:185-191.
6. Langeveld M., Scheij S., Dubbelhuis P., Hollak C.E., Sauerwein H.P., Simons P., Aerts J.M. Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia. Metabolism 2007, 56:314-319.
7. Langeveld M., de Fost M., AertS J.M., Sauerwein H.P., Hollak C.E. Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy. Blood Cells Mol. Dis. 2008, 40:428-432.
8. Elstein D., Zimran A. Review of the safety and efficacy of imiglucerase treatment of Gaucher disease. Biologics Targets Therapy 2009, 3:407-417.
9. Langeveld M., Ghauharali K.J., Sauerwein H.P., Ackermans M.T., Groener J.E., Hollak C.E., Aerts J.M., Serlie M.J. Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. J. Clin. Endocrinol. Metab. 2008, 93:845-851.
10. Ucar S.K., Coker M., Argin M., Akman S., Kara S., Simsek D.G., Darcan S. A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight. Mol. Genet. Metab. 2009, 96:50-51.
11. Ghauharali K., Langeveld M., Poppema A., Kuiper S., Hollak C.E., Aerts J.M., Groener J.E. Proeminent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clin. Chim. Acta 2008, 389:109-113.
12. Compher C., Frankenfield D., Keim N., Roth-Yousey L. Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review. J. Am. Diet. Assoc. 2006, 106:881-903.
13. WHO (World Health Organization) Physical status: the use and interpretation of anthropometry 1995, Geneva, Switzerland (Report no 854).
14. WHO (World Health Organization) Obesity: preventing and managing the global epidemic 1997, Geneva, Switzerland, (Report no 981).
15. WHO (World Health Organization) Growth reference data for 5-19 years Accessed on 06/21/2010. http://www.who.int/growthref/en/.
16. Zimran A., Kay A., Gelbart T., Garver P., Thurston D., Saven A., Beutler E. The natural history of adult type I Gaucher disease: clinical, laboratory, radiologic and genetic features of 53 patients. Medicine (Baltimore) 1992, 71:337-353.
17. Weir J.B. New methods for calculating metabolic rate with special reference to protein metabolism. J. Physiol. 1949, 109:1-9.
18. Harris J.A., Benedict F.G. A biometric study of basal metabolism in man 1919, Carnegie Institute of Washington, Washington, DC.
19. Henry C.J.K. Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr. 2005, 8:1133-1152.
20. Poehlman E.T., Horton H.S. Energy needs: assessment and requirements in humans. Modern Nutrition in health and disease 1999, 95-104. Lippinncott Willians & Wilkins, Baltimore. 9th ed. M.E. Shils (Ed.).
21. Kauli R., Zaizov R., Lazar L., Pertzelan A., Laron Z., Galatzer A., Phillip M., Yaniv Y., Cohen I.J. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. Isr. Med. Assoc. J. 2000, 2:158-163.
22. Langeveld M., Endert E., Wiersinga W.M., Aerts J.M., Hollak C.E. Hypermetabolism in Gaucher disease type I is not associated with altered thyroid hormone levels. J. Inherit. Metab. Dis. 2007, 30:985.
23. Mariani G., Erba P.A. Radionuclide Evaluation of Gaucher Disease. Gaucher Disease 2007, 287-319. CRC Taylor & Francis, Boca Raton. A.H. Futerman, A. Zimran (Eds.).
24. Mistry P.K. Zimran. Type 1 Gaucher Disease - Clinical Features. Gaucher Disease 2007, 155-173. CRC Taylor & Francis, Boca Raton. A.H. Futerman, A. Zimran (Eds.).
25. Cruz C.M., Silva A.F., Anjos L.A. A taxa metabólica é superestimada pelas equações preditivas em universitárias do Rio de Janeiro, Brasil. Arch. Latinoam. Nutr. 1999, 49:232-237.
26. Wahrlich V., Anjos L.A. Validação de equações de predição da taxa metabólica basal em mulheres residentes em Porto Alegre. Brasil. Rev Saúde Pública. 2001, 35:39-45.
27. Wahrlich V., Anjos L.A., Going S.B., Lohman T.G. Basal metabolic rate of Brazilians living in the Southwestern United States. Eur. J. Clin. Nutr. 2007, 61:289-293.
28. Boven L.A., van Meurs M., Boot R.G., Mehta A., Boon L., Aerts J.M., Laman J.D. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am. J. Clin. Pathol. 2004, 122:359-369.